SCHEMBL24865615

SCHEMBL24865615

Cc1cc(N2CC(C)OC(C)C2)ccc1N

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 4/20 0.50
RAD52 P43351 2/20 0.50
MAPT P10636 5/20 0.45
ALDH1A1 P00352 6/20 0.41
KDM4E B2RXH2 3/20 0.41
RAB9A P51151 1/20 0.41
THRB P10828 1/20 0.40
TSHR P16473 2/20 0.38
CYP3A4 P08684 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
KMT2A Q03164 2/20 0.37
ADORA2A P29274 1/20 0.37
ADORA1 P30542 1/20 0.37
HSD17B10 Q99714 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
LGMN Q99538 1/20 0.36
MAPK1 P28482 1/20 0.36
HTT P42858 1/20 0.36
RECQL P46063 1/20 0.36
PTK2B Q14289 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14892767 0.86 MAPT (0.47) GAAMAPTALDH1A1KDM4ERAB9A
SCHEMBL21000993 0.86 MAPT (0.47) GAAMAPTALDH1A1KDM4ERAB9A
SCHEMBL18436367 0.84 MAPT (0.49) GAAMAPTALDH1A1KDM4ERAB9A
SCHEMBL18436856 0.84 MAPT (0.49) GAAMAPTALDH1A1KDM4ERAB9A
SCHEMBL30279171 0.82 MAPT (0.44) GAAMAPTALDH1A1KDM4ERAB9A
SCHEMBL13716407 0.82 MAPT (0.44) GAAMAPTALDH1A1KDM4ERAB9A
SCHEMBL6709032 0.81 GAA (0.54) GAARAD52MAPTALDH1A1KDM4E
SCHEMBL18436015 0.80 MAPT (0.45) GAAMAPTALDH1A1KDM4ERAB9A
SCHEMBL20180514 0.80 GAA (0.50) GAARAD52MAPTALDH1A1KDM4E
SCHEMBL27679121 0.80 RAD52 (0.50) GAARAD52MAPTALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240360114-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2024-10-31 US disclosed
US-20240327393-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2024-10-03 US disclosed
EP-4384493-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd (KY) 2024-06-19 EP disclosed
CN-118076581-A Iron death modulators, their preparation and use 维泰瑞隆有限公司 2024-05-24 CN disclosed
CN-117999259-A Iron death modulators, their preparation and use 维泰瑞隆有限公司 2024-05-07 CN disclosed
WO-2023016447-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2023-02-16 WO disclosed
WO-2023280296-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2023-01-12 WO disclosed
WO-2023280296-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF Sironax Ltd. (KY) 2023-01-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240360114-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF AIFM2, GPX1, GPX4 GAA 771/4885RAD52 3840/4885MAPT 2954/4885
US-20240327393-A1 FERROPTOSIS MODULATORS, PREPARATIONS, AND USES THEREOF AIFM2, GPX1, GPX4 GAA 861/4885RAD52 3798/4885MAPT 3110/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.